Archive for August, 2017

Trying to get it right: a blog carnival about Right to Try

Author: Stacey Johnson, 08/29/17

The crux of Right to Try legislation, enacted by 37 U.S. states so far, is the premise that terminally ill patients should have access to experimental therapies, even if they haven’t been approved by the Food and Drug Administration yet. It sounds straight-forward right? My body, my risk, my decision. The U.S. already has measures…Read more

Valuing the good, the bad and the ugly

Author: David Kent, 08/29/17

As with all of my posts that relate to anything that might end up being a medical treatment, it is important to be very clear that I am scientist and not a physician.  My comments are my own opinion and based on my experience as a stem cell biologist over the last 10+ years. This…Read more

A prescription of hope

Author: Guest, 08/29/17

By Brian Sladek I am honoured to have my blog be just one of several covering this topic as part of Signal’s second annual blog carnival on the theme ‘Right to Try.’ Please click here to read what other bloggers think of this. As a patient, I don’t care about percentages. According to a recent SEER…Read more

An ivory tower perspective of the right-to-try movement: We need to balance the equation

Author: Guest, 08/29/17

Patrick Bedford is the Senior Manager of Clinical Translation and Regulatory Affairs at CCRM. He holds a Master’s Degree in Bioethics and Health Law, and a Regulatory Affairs Certificate. Patrick has spent over 11 years applying federal regulations to emerging biotechnologies in Canada. Follow him on LinkedIN. Do desperate times call for desperate measures in the context…Read more

Right Turn: ‘Right to try’ state of affairs in U.S.

Author: Stacey Johnson, 08/25/17

On Tuesday, August 29, Signals is hosting a blog carnival on the topic Right to Try. Before you read the perspectives of the contributing bloggers, here’s what President Trump thinks about the legislation and the Goldwater Institute’s reaction. It’s the Institute that took on this cause in the first place. Earlier this month, the U.S….Read more

Weighing in on a controversial topic

Author: Stacey Johnson, 08/23/17

We are less than one week away from Signals’ second blog carnival! Last month I promised to reveal the topic and the participants. I also hinted that this year’s topic might strike some readers as controversial. Given that a few invited bloggers declined to participate, I’d have to say that’s the case. So although our…Read more

Right Turn: Vacationing on Mars

Author: Stacey Johnson, 08/18/17

Hi Loyal Readers, Happy summer! Thanks for your visits all year. I’m on vacation this week, but I thought I’d leave you with something anyway. Next week, I’ll provide some more details about the upcoming blog carnival taking place August 29th. I hope you’ll drop by to read all the interesting blogs and different points…Read more

Right Turn: Small device packs big potential

Author: Stacey Johnson, 08/11/17

Whenever something sounds too good to be true, it usually is. The expression is used widely in a variety of contexts, one of which is as a warning to avoid being taken in by a scam or taken advantage of. Unfortunately, it applies to the stem cell field too. I am tempted to state that…Read more

BRM2017: State of the regenerative medicine industry

Author: Stacey Johnson, 08/09/17

Although new to the field of science communication, Nathan Holwell has been involved in a variety of research during his undergraduate career and now in his graduate career. He has done research in drug delivery, gene delivery, biomaterials and diagnostic devices. His graduate research at Queen’s University, where he is pursuing a PhD in Chemical…Read more

Right Turn: The why and how of communicating science to media

Author: Stacey Johnson, 08/04/17

Engaging with the media is not for the faint of heart, but speaking on behalf of the entire world, we need you to step up scientists! Your research is important and valuable, and you may (I chose that word deliberately) be the best person to communicate it. So, while the prospect of doing a media…Read more